Drug - Publications - Faculty & Research

Show Results For

← Page 31 of 610 Results

Sort by

Are you looking for?

29 Jan 2013
First Look

First Look: Jan. 29

facing the scientific founder and CEO of a promising, early stage bio-pharmaceuticals company. Should the company establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging... View Details

Keywords: Sean Silverthorne

13 Sep 2011
First Look

First Look: September 13

come primarily from the non-drug treatment (87.4% and 70.2% respectively), whereas gains from detailing come at the expense of competing drugs (84%). By contrast, the random coefficient logit model predicts that gains from DTCA, M&E,... View Details

Keywords: Sean Silverthorne

18 Sep 2007
First Look

First Look: September 18, 2007

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=907025 NatuRi Corporation Harvard Business School Case 807-027 NatuRi Corporation was a start up, founded in 2005, aiming to manufacture a cholesterol-lowering drug made from... View Details

Keywords: Martha Lagace

12 Feb 2008
First Look

First Look: February 12, 2007

stake of 9.5% in Ligand Pharmaceuticals, Inc., a specialty pharmaceutical company. Third Point believed that Ligand had a strong drug portfolio and pipeline but that it was highly undervalued due to poor management. After gaining board... View Details

Keywords: Martha Lagace

21 Apr 2009
First Look

First Look: April 21, 2009

Industry Location Author:Arthur A. Daemmrich Abstract A consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a... View Details

Keywords: Martha Lagace